High-throughput screening of biocatalytic activity: applications in drug discovery.
Enzymes catalyze a diverse set of reactions that propel life's processes and hence serve as valuable therapeutic targets. High-throughput screening methods have become essential for sifting through large chemical libraries in search of drug candidates, and several sensitive and reliable analytical techniques have been specifically adapted to high-throughput measurements of biocatalytic activity. High-throughput biocatalytic assay platforms thus enable rapid screening against enzymatic targets, and have vast potential to impact various stages of the drug discovery process, including lead identification and optimization, and ADME/Tox assessment. These advances are paving the way for the adoption of high-throughput biocatalytic assays as an indispensable tool for the pharmaceutical industry.
Kumar
R Anand
RA
Department of Chemical Engineering, University of California, Berkeley, CA 94720, USA.
Clark
Douglas S
DS
D002384:Catalysis; D015195:Drug Design; D004798:Enzymes / Q000378:metabolism; D010599:Pharmacokinetics; D018675:Toxicity Tests
D004798:Enzymes